DRIVING RESTRICTIONS ADVISED BY MIDWESTERN CARDIOLOGISTS IMPLANTING CARDIOVERTER DEFIBRILLATORS - PRESENT PRACTICES, CRITERIA UTILIZED, AND COMPATIBILITY WITH EXISTING STATE LAWS

被引:13
作者
DICARLO, LA
WINSTON, SA
HONOWAY, S
REED, P
机构
[1] MICHIGAN HEART & VASC INST,CARDIAC ELECTROPHYSIOL LAB,ANN ARBOR,MI
[2] ST JOSEPH MERCY HOSP,DEPT SOCIAL SERV,ANN ARBOR,MI 48104
[3] UNIV MICHIGAN,SCH MED,ANN ARBOR,MI 48104
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1992年 / 15卷 / 08期
关键词
ANTITACHYCARDIA DEVICES; CARDIOVERTER DEFIBRILLATOR; SYNCOPE; VENTRICULAR TACHYCARDIA; VENTRICULAR FIBRILLATION;
D O I
10.1111/j.1540-8159.1992.tb03115.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although some patients remain at risk of losing physical control or collapsing after implantation of a cardioverter defibrillator for sustained ventricular arrhythmias, little is known about restrictions advised by arrhythmia specialists to patients with implanted devices concerning physical activities such as driving. In this study, all of the 58 cardiologists implanting cardioverter defibrillators in three contiguous midwestern states were surveyed to determine present practices and the compatibility of these practices with existing state law. Of the 51 respondents (88%), 27 cardiologists (53%) advised only those implanted patients who had had arrhythmia-induced presyncope or physical collapse to cease driving. Twenty two of the remaining cardiologists (43%) advised all implanted patients to cease driving, whereas two cardiologists (4%) never advised any implanted patient to restrict driving. Permanent driving abstinence was advised by seven of the responding cardiologists (14%), while temporary driving abstinence for periods of 2-12 months (mean 6 +/- 3 months) was recommended by the remaining 42 respondents (82%) who advised against driving. The criteria utilized, driving restrictions advised, and durations advised for driving restrictions were not uniform in any of the 13 surveyed university and nonaffiliated cardiology practices with greater-than-or-equal-to 2 implanting cardiologists. Overall, 38 cardiologists (74%) advised against driving and recommended durations that equaled or exceed their state's minimum legal requirements, although only 27 of the 51 cardiologists (53%) based their practice upon knowledge of their state's driving laws. The results of this survey suggest that the majority of cardiologists who implant cardioverter defibrillators advise their patients against driving postoperatively. However, the criteria and durations utilized in advising driving abstinence are not uniform and do not always conform with existing state laws.
引用
收藏
页码:1131 / 1136
页数:6
相关论文
共 18 条
[1]   THE USE OF BEEP-O-GRAMS IN THE ASSESSMENT OF AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SENSING FUNCTION [J].
BALLAS, SL ;
RASHIDI, R ;
MCALISTER, H ;
CORBELLI, R ;
MCCOWAN, R ;
WILKOFF, BL ;
CASTLE, LW ;
MORANT, VA ;
SIMMONS, TW ;
MALONEY, JD .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1989, 12 (11) :1737-1745
[2]   THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - CLINICAL-EXPERIENCE, COMPLICATIONS, AND FOLLOW-UP IN 25 PATIENTS [J].
BORBOLA, J ;
DENES, P ;
EZRI, MD ;
HAUSER, RG ;
SERRY, C ;
GOLDIN, MD .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (01) :70-76
[3]   CLINICAL-EXPERIENCE, COMPLICATIONS, AND SURVIVAL IN 70 PATIENTS WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
ECHT, DS ;
ARMSTRONG, K ;
SCHMIDT, P ;
OYER, PE ;
STINSON, EB ;
WINKLE, RA .
CIRCULATION, 1985, 71 (02) :289-296
[4]   THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN DRUG-REFRACTORY VENTRICULAR TACHYARRHYTHMIAS [J].
FOGOROS, RN ;
FIEDLER, SB ;
ELSON, JJ .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (05) :635-641
[5]   AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - PATIENT SURVIVAL, BATTERY LONGEVITY AND SHOCK DELIVERY ANALYSIS [J].
GABRY, MD ;
BRODMAN, R ;
JOHNSTON, D ;
FRAME, R ;
KIM, SG ;
WASPE, LE ;
FISHER, JD ;
FURMAN, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (06) :1349-1356
[6]   THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - EFFICACY, COMPLICATIONS AND SURVIVAL IN PATIENTS WITH MALIGNANT VENTRICULAR ARRHYTHMIAS [J].
KELLY, PA ;
CANNOM, DS ;
GARAN, H ;
MIRABAL, GS ;
HARTHORNE, JW ;
HURVITZ, RJ ;
VLAHAKES, GJ ;
JACOBS, ML ;
ILVENTO, JP ;
BUCKLEY, MJ ;
RUSKIN, JN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 11 (06) :1278-1286
[7]   PROVOCATION OF VENTRICULAR-TACHYCARDIA BY AN AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR [J].
KOU, WH ;
KIRSH, MM ;
STIRLING, MC ;
KADISH, AH ;
ORRINGER, CE ;
MORADY, F .
AMERICAN HEART JOURNAL, 1990, 120 (01) :208-210
[8]  
KOU WH, 1990, PACE, V13, P528
[9]   THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN YOUNG-PATIENTS [J].
KRON, J ;
OLIVER, RP ;
NORSTED, S ;
SILKA, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (04) :896-902
[10]  
LARSEN GC, 1990, CIRCULATION, V82, P83